Mascioli, D., Conti, M., Bissacco, J., Bovenzi, R., Simonetta, C., Buttarazzi, V., . . . Schirinzi, T. (2025). Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson's disease patients independently of APOE. Neurobiology of Aging, 155, 1. https://doi.org/10.1016/j.neurobiolaging.2025.07.004
Chicago Style (17th ed.) CitationMascioli, Davide, et al. "Serum HDL-cholesterol Is Associated with the Clinical-biological Profile of Early-stage Parkinson's Disease Patients Independently of APOE." Neurobiology of Aging 155 (2025): 1. https://doi.org/10.1016/j.neurobiolaging.2025.07.004.
MLA (9th ed.) CitationMascioli, Davide, et al. "Serum HDL-cholesterol Is Associated with the Clinical-biological Profile of Early-stage Parkinson's Disease Patients Independently of APOE." Neurobiology of Aging, vol. 155, 2025, p. 1, https://doi.org/10.1016/j.neurobiolaging.2025.07.004.